Topos Bio, Inc.
Developer of an AI- and biophysics-integrated discovery platform focused on intrinsically disordered proteins (IDPs). The platform combines ensemble-level computational modeling, generative molecular design, and high-throughput experimental validation to identify binding pockets, transient motifs, and intervention strategies. Programs emphasize small molecules, peptides, and targeted degraders and the organization pursues collaborative partnerships from early discovery to co-development.
Industries
Artificial Intelligence (AI)
Health Care
Biotechnology Research
Nr. of Employees
small (1-50)
Services
Integrated discovery service combining ensemble-level computational modeling, AI-driven generative design, and high-throughput experimental validation to discover and advance candidates against intrinsically disordered proteins.
Integrated discovery service combining ensemble-level computational modeling, AI-driven generative design, and high-throughput experimental validation to discover and advance candidates against intrinsically disordered proteins.
Expertise Areas
- Intrinsically disordered protein targeting
- AI-driven drug discovery
- Biophysics-informed computational modeling
- Ensemble molecular simulation
Key Technologies
- Ensemble molecular simulations
- Biophysics-informed computational chemistry
- Deep generative models for molecular design
- Machine learning for protein modeling